PULSE BIOSCIENCES, INC.
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Nov 5, 2026 (10 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 13, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Oct 6, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Sep 23, 2026 | BTIG | initiate | — → Buy | — | 52% |
| Sep 9, 2026 | Freedom Capital Markets | initiate | — → Buy | — | 43% |
| Aug 17, 2026 | Needham | initiate | — → Buy | — | 50% |
| Aug 10, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jun 4, 2026 | Canaccord Genuity | initiate | — → Buy | — | 48% |
| Jul 7, 2025 | Oppenheimer | initiate | — → Outperform | $22 | 52% |
| Sep 21, 2022 | Maxim Group | downgrade | Buy → Hold | $0 | 42% |
| May 13, 2022 | HC Wainwright & Co. | downgrade | Buy → Neutral | $0 | 44% |
| Apr 1, 2022 | Stephens & Co. | maintain | — → Overweight | $12 | 54% |
| Apr 1, 2022 | HC Wainwright & Co. | maintain | — → Buy | $8.5 | 44% |
| Feb 10, 2022 | HC Wainwright & Co. | maintain | — → Buy | $20 | 44% |
| Nov 16, 2021 | HC Wainwright & Co. | maintain | — → Buy | $43 | 44% |
| Jul 27, 2021 | Stephens & Co. | initiate | — → Overweight | $28 | 54% |
| Mar 11, 2021 | Maxim Group | initiate | — → Buy | $40 | 42% |
| Jan 26, 2021 | HC Wainwright & Co. | maintain | — → Buy | $40 | 44% |
| May 12, 2020 | HC Wainwright & Co. | upgrade | Neutral → Buy | $16 | 44% |
| Feb 14, 2020 | HC Wainwright & Co. | downgrade | Buy → Neutral | $6 | 44% |
| Feb 25, 2019 | HC Wainwright & Co. | initiate | — → Buy | $0 | 44% |
No cross-platform signals in the last 90 days